Correlation Between Lineage Cell and Solid Biosciences

Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lineage Cell Therapeutics and Solid Biosciences LLC, you can compare the effects of market volatilities on Lineage Cell and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Solid Biosciences.

Diversification Opportunities for Lineage Cell and Solid Biosciences

0.88

Correlation Coefficient

Lineage Cell  Solid Biosciences

Very poor diversification

The 3 months correlation between Lineage and Solid is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Lineage Cell i.e., Lineage Cell and Solid Biosciences go up and down completely randomly.

Pair Corralation between Lineage Cell and Solid Biosciences

Given the investment horizon of 90 days Lineage Cell is expected to generate 1.05 times less return on investment than Solid Biosciences. In addition to that, Lineage Cell is 1.22 times more volatile than Solid Biosciences LLC. It trades about 0.25 of its total potential returns per unit of risk. Solid Biosciences LLC is currently generating about 0.32 per unit of volatility. If you would invest  277.00  in Solid Biosciences LLC on May 16, 2025 and sell it today you would earn a total of  391.00  from holding Solid Biosciences LLC or generate 141.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Lineage Cell Therapeutics  vs.  Solid Biosciences LLC

Lineage Cell Therapeutics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Lineage Cell Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Lineage Cell showed solid returns over the last few months and may actually be approaching a breakup point.

Solid Biosciences LLC

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Solid Biosciences LLC are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Solid Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lineage Cell and Solid Biosciences

The main advantage of trading using opposite Lineage Cell and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.

The idea behind Lineage Cell Therapeutics and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.